Stahl’s Essential Psychopharmacology 5th
Edition Test Bank
Psychopharmacologic Goal - Optimize patient and risk stratification
Unwritten Drugs - Should be continued
Dated Terms - Include antipsychotics and mood stabilizers
Schizophrenia Etiology - Is unknown
Schizophrenia Age Onset - Occurs between 16 to 30 years old
Schizophrenia Symptoms - Include positive and negative symptoms
Positive Symptoms Examples - Delusions, hallucinations, reality distortions
Negative Symptoms Examples - Flat affect, social withdrawal, anhedonia
Paranoia Development - Leads to reality distortions
Schizophrenia DSM-5 Diagnosis - Requires one positive symptom
Schizophrenia Genetic Factor - High genetic factor and brain functioning involvement
Etiologic Factors - Include genetic, brain function, and various proteins
Schizophrenia Pathways - Mesolimbic and mesocortical
Positive Symptoms Overactivity - Linked to mesolimbic pathway
, Negative Symptoms Dysfunction - Linked to mesocortical pathway
Delusions Treatment Goal - Decrease frequency of invasive thoughts
Delusions Persistence - Never completely go away
Hallucinations Types - Auditory may disappear
FGA vs. SGA Drugs - First generation (typical) vs. second generation (atypical)
FGA Drug Receptor - Primarily D2 receptors
Atypical Drug Receptors - Include serotonin in addition to dopamine
SGA Side Effects - Include metabolic syndrome
FGA Drug Endings - Phenothiazine, -zide, -idol, -xene
SGA Drug Endings - -pine, -done, -zole
EKG Leads for Monitoring - 3 leads for arrhythmia, 5 leads for arrhythmia and ischemia
MDD Risk Factors - Higher in females, 18-29, with family history
DSM-5 MDD Episode - Criteria: >5 symptoms for >2 weeks daily
Mixed Features in MDD - High manic episodes, low depressive states
SIGECAPS in MDD - Acronym for clinical presentations
MDD Emotional Symptoms - Include inability to experience pleasure
MDD Physical Symptoms - Include fatigue, pain, sleep disturbance
MDD Cognitive Symptoms - Include confusion, memory loss, decreased concentration
MDD Psychomotor Symptoms - Include slow movements, agitation
Etiology of MDD - Mainly unknown
Proposed Etiology of MDD - Involves changes in monoamine neurotransmitter action
Non-Pharmacologic Therapies for MDD - Include psychotherapy, ECT, light therapy
Serotonin Subclasses - 1A - antidepressant, 2A - anxiety, insomnia
Edition Test Bank
Psychopharmacologic Goal - Optimize patient and risk stratification
Unwritten Drugs - Should be continued
Dated Terms - Include antipsychotics and mood stabilizers
Schizophrenia Etiology - Is unknown
Schizophrenia Age Onset - Occurs between 16 to 30 years old
Schizophrenia Symptoms - Include positive and negative symptoms
Positive Symptoms Examples - Delusions, hallucinations, reality distortions
Negative Symptoms Examples - Flat affect, social withdrawal, anhedonia
Paranoia Development - Leads to reality distortions
Schizophrenia DSM-5 Diagnosis - Requires one positive symptom
Schizophrenia Genetic Factor - High genetic factor and brain functioning involvement
Etiologic Factors - Include genetic, brain function, and various proteins
Schizophrenia Pathways - Mesolimbic and mesocortical
Positive Symptoms Overactivity - Linked to mesolimbic pathway
, Negative Symptoms Dysfunction - Linked to mesocortical pathway
Delusions Treatment Goal - Decrease frequency of invasive thoughts
Delusions Persistence - Never completely go away
Hallucinations Types - Auditory may disappear
FGA vs. SGA Drugs - First generation (typical) vs. second generation (atypical)
FGA Drug Receptor - Primarily D2 receptors
Atypical Drug Receptors - Include serotonin in addition to dopamine
SGA Side Effects - Include metabolic syndrome
FGA Drug Endings - Phenothiazine, -zide, -idol, -xene
SGA Drug Endings - -pine, -done, -zole
EKG Leads for Monitoring - 3 leads for arrhythmia, 5 leads for arrhythmia and ischemia
MDD Risk Factors - Higher in females, 18-29, with family history
DSM-5 MDD Episode - Criteria: >5 symptoms for >2 weeks daily
Mixed Features in MDD - High manic episodes, low depressive states
SIGECAPS in MDD - Acronym for clinical presentations
MDD Emotional Symptoms - Include inability to experience pleasure
MDD Physical Symptoms - Include fatigue, pain, sleep disturbance
MDD Cognitive Symptoms - Include confusion, memory loss, decreased concentration
MDD Psychomotor Symptoms - Include slow movements, agitation
Etiology of MDD - Mainly unknown
Proposed Etiology of MDD - Involves changes in monoamine neurotransmitter action
Non-Pharmacologic Therapies for MDD - Include psychotherapy, ECT, light therapy
Serotonin Subclasses - 1A - antidepressant, 2A - anxiety, insomnia
